Pdt Partners, LLC Catalyst Biosciences, Inc. Transaction History

Pdt Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.91 - $4.16 $19,622 - $89,702	-21,563 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.78 - $5.18 $36,926 - $50,603	9,769 Added 82.83%	21,563 $89,000
Q2 2021 Aug 16, 2021	SELL	$4.1 - $5.33 $177,144 - $230,287	-43,206 Reduced 78.56%	11,794 $51,000
Q1 2021 May 17, 2021	BUY	$4.93 - $7.15 $99,586 - $144,430	20,200 Added 58.05%	55,000 $277,000
Q4 2020 Feb 16, 2021	SELL	$4.55 - $7.29 $28,715 - $46,007	-6,311 Reduced 15.35%	34,800 $220,000
Q3 2020 Nov 16, 2020	BUY	$4.22 - $6.04 $81,070 - $116,034	19,211 Added 87.72%	41,111 $177,000
Q2 2020 Aug 14, 2020	SELL	$3.76 - $8.01 $7,704 - $16,412	-2,049 Reduced 8.56%	21,900 $129,000
Q1 2020 May 15, 2020	BUY	$3.5 - $8.51 $42,871 - $104,238	12,249 Added 104.69%	23,949 $105,000
Q4 2019 Feb 14, 2020	SELL	$4.52 - $7.91 $73,224 - $128,142	-16,200 Reduced 58.06%	11,700 $80,000
Q2 2019 Aug 14, 2019	BUY	$7.08 - $10.6 $197,532 - $295,740	27,900 New	27,900 $206,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.